Tag

Bayer

All articles tagged with #bayer

Trump shields glyphosate production with executive order amid lawsuits
politics6 days ago

Trump shields glyphosate production with executive order amid lawsuits

President Trump signed an executive order under the Defense Production Act to secure domestic production of glyphosate-based herbicides like Roundup and elemental phosphorus, granting immunity to manufacturers and arguing the move is essential to national security and food supply. Health and environmental groups criticize it amid thousands of lawsuits alleging cancer risks, while Bayer says it will comply and pursues preemption in courts; the policy could affect litigation as a Supreme Court preemption case awaits in April.

Bayer tees up $7.25B settlement to wrap Roundup cancer lawsuits
business7 days ago

Bayer tees up $7.25B settlement to wrap Roundup cancer lawsuits

Bayer and plaintiffs’ lawyers unveiled a proposed nationwide settlement of up to $7.25 billion to resolve more than 125,000 U.S. Roundup cancer lawsuits, funded over as many as 21 years with payouts varying by exposure and age. The deal, which still needs Missouri court approval, would provide compensation even if the Supreme Court sides with Bayer on labeling preemption, while potentially shielding the company from larger future costs. Separately, Bayer has halted glyphosate in U.S. residential markets but continues its use in agriculture; regulators say glyphosate is unlikely to be carcinogenic when used as directed. Some plaintiffs’ attorneys say payouts are too small and opt-outs could derail the agreement.),

Bayer promotes $7.25B plan to settle Roundup lawsuits without admitting fault
business8 days ago

Bayer promotes $7.25B plan to settle Roundup lawsuits without admitting fault

Bayer's Monsanto unit proposed a $7.25 billion settlement to resolve Roundup non-Hodgkin lymphoma lawsuits, with annual payments over up to 21 years if approved; the deal includes no admission of liability and would lift Bayer's total litigation liability to about €11.8 billion, plus roughly €3 billion in other Roundup settlements. The lawsuits stem from Bayer's 2018 acquisition of Monsanto, and Roundup remains on the market as Bayer maintains its safety claims.

Supreme Court to decide Bayer’s bid to block thousands of Roundup lawsuits
law1 month ago

Supreme Court to decide Bayer’s bid to block thousands of Roundup lawsuits

The Supreme Court agreed to hear Bayer’s appeal aimed at blocking thousands of state lawsuits alleging the Roundup weedkiller causes cancer, weighing whether EPA approval without a cancer warning should defeat the claims. The Trump administration backs Bayer, reversing the Biden administration, while EPA officials say glyphosate is unlikely to be carcinogenic when used as directed. Bayer has set aside about $16 billion to settle claims and has pushed for state-level immunity laws, with Georgia and North Dakota enacting such measures. A Missouri case involving non-Hodgkin’s lymphoma is part of the docket, and Bayer faces roughly 181,000 claims overall. A 2024 appellate ruling favored Bayer, and the company has signaled it could remove glyphosate from U.S. residential markets but would retain it for agriculture; timing for arguments remains uncertain.

Bayer Faces Supreme Court Test Over Roundup Liability Preemption
business1 month ago

Bayer Faces Supreme Court Test Over Roundup Liability Preemption

The US Supreme Court agreed to hear Bayer AG’s appeal challenging thousands of Roundup lawsuits, focusing on whether federal pesticide law preempts state-level failure-to-warn claims. Bayer seeks to dismiss many cases while still facing roughly 67,000 claims, with billions already paid in verdicts and settlements and more reserved. The ruling could harmonize preemption standards across courts and impact the trajectory of Roundup litigation.

Judge Reduces Bayer Roundup Verdict to $400 Million
legal1 year ago

Judge Reduces Bayer Roundup Verdict to $400 Million

A Pennsylvania judge reduced a $2.25 billion verdict against Bayer to $400 million for a man who developed cancer from using Roundup weedkiller. Bayer plans to appeal, arguing the trial had significant errors, while the plaintiff's attorneys also plan to appeal to reinstate the original verdict. Bayer has faced numerous lawsuits over Roundup, with mixed trial outcomes and significant financial implications.

"Corporate Influence and Legal Loopholes: The Battle Over Toxic Chemicals"
business-legal-agriculture1 year ago

"Corporate Influence and Legal Loopholes: The Battle Over Toxic Chemicals"

Bayer, facing billions in settlements and trials over claims that its weedkiller Roundup causes cancer, is lobbying lawmakers in Iowa, Missouri, and Idaho to pass bills providing legal immunity from such lawsuits. The legislation, supplied by Bayer, would shield pesticide companies from failure-to-warn claims if their labels comply with EPA regulations, but critics warn it could have broader consequences and stifle product liability claims. Farmers and lawmakers supporting the bills argue that Roundup is a crucial tool for agriculture, while opponents express concerns about corporate immunity and potential risks to public health.

"Bayer's 95% Dividend Cut to Tackle Debt"
business2 years ago

"Bayer's 95% Dividend Cut to Tackle Debt"

Bayer AG plans to reduce its dividend by 95% in an attempt to address financial challenges stemming from its acquisition of Monsanto Co., which burdened the company with significant debt and legal battles related to Roundup herbicide. The dividend cut reflects the company's struggle to manage its debt pile of over €38.7 billion amid mounting legal costs and rising interest rates. Bayer's decision to slash its dividend comes as it grapples with ongoing litigation, patent expirations, and declining sales in its crop science and pharmaceutical divisions, prompting the need for strategic actions to restore its balance sheet and financial flexibility.

"US Court Rulings Shake Up Weedkiller Approvals and Availability"
agriculture-and-environment2 years ago

"US Court Rulings Shake Up Weedkiller Approvals and Availability"

A U.S. court has invalidated the government's recent approvals of dicamba-based weedkillers from Bayer, BASF, and Syngenta, causing uncertainty for farmers who use the products on genetically engineered soybeans and cotton. The court ruling was in response to the Environmental Protection Agency's violation of public input procedures. The decision affects widely used herbicides such as Bayer's XtendiMax and BASF's Engenia, with potential financial implications for farmers and disruptions to supply chains. The companies are awaiting guidance from the EPA, and the ruling prohibits the use of dicamba products in the upcoming growing season unless existing stocks are allowed to be used.

"US Court Halts Dicamba Use, Finding EPA Broke Law in Approval Process"
environment2 years ago

"US Court Halts Dicamba Use, Finding EPA Broke Law in Approval Process"

A US court has banned three dicamba-based weedkillers widely used in American agriculture, finding that the EPA broke the law in allowing them to be on the market. The ruling affects products manufactured by Bayer, BASF, and Syngenta, and comes after the EPA reapproved the weedkillers in 2020. The court found that the EPA did not follow proper procedures and did not allow affected parties to comment. This decision is a blow to the agrochemical companies and comes at a challenging time for Bayer, which is already facing mass litigation over Monsanto's glyphosate-based Roundup herbicides.